Multiple adaptive routes of Salmonella enterica Typhimurium to biocide and antibiotic exposure

BMC Genomics

Volumn 17, Issue 1, 2016, Pages

  Curiao, Tânia ^a,b   Marchi, Emmanuela ^d   Grandgirard, Denis ^e   León Sampedro, Ricardo ^a,b   Viti, Carlo ^d   Leib, Stephen L ^e   Baquero, Fernando ^a,b,c   Oggioni, Marco R ^f   Martinez, José Luis ^c,g   Coque, Teresa M ^a,b,c  

^a INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c CSIC   (Spain)

^d UNIVERSITY OF FLORENCE   (Italy)

^e Institute for Infectious Diseases   (Switzerland)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Antimicrobial susceptibility; Biocide resistance; Collateral sensitivity; Transcriptomics; WGS

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BENZALKONIUM; BIOCIDE; CHLORHEXIDINE; CIPROFLOXACIN; COLISTIN; HYPOCHLORITE SODIUM; PHOSPHOTRANSFERASE; POLYLYSINE; POLYMYXIN B; TRICLOSAN; ANTIINFECTIVE AGENT; DISINFECTANT AGENT;

AEROBIC METABOLISM; AMINO ACID METABOLISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIUM ISOLATE; CARBOHYDRATE METABOLISM; COLD SHOCK RESPONSE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG EXPOSURE; ENERGY YIELD; GENE EXPRESSION; GENOMICS; LIPID METABOLISM; MEMBRANE TRANSPORT; NONHUMAN; PHENOTYPE; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; ADAPTATION; ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; CLUSTER ANALYSIS; DRUG EFFECTS; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SEQUENCING; MICROBIAL SENSITIVITY TEST; MUTATION; PHYSIOLOGY; REPRODUCTIVE FITNESS;

ADAPTATION, BIOLOGICAL; ANTI-BACTERIAL AGENTS; CLUSTER ANALYSIS; DISINFECTANTS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION PROFILING; GENES, BACTERIAL; GENETIC FITNESS; GENOME, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MICROBIAL SENSITIVITY TESTS; MUTATION; SALMONELLA TYPHIMURIUM;

EID: 84979665824     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-016-2778-z     Document Type: Article

References (58)

1. Parry CM, Threlfall EJ. Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis. 2008;21:531-8.
2. Barat S, Steeb B, Mazé A, Bumann D. Extensive in vivo resilience of persistent Salmonella. PLoS One. 2012;7:e42007.
3. Condell O, Iversen C, Cooney S, Power KA, Walsh C, Burgess C, Fanning S. Efficacy of biocides used in the modern food industry to control Salmonella enterica, and links between biocide tolerance and resistance to clinically relevant antimicrobial compounds. Appl Environ Microbiol. 2012;78:3087-97.
4. Beier RC, Anderson PN, Hume ME, Poole TL, Duke SE, Crippen TL, Sheffield CL, Caldwell DJ, Byrd JA, Anderson RC, Nisbet DJ. Characterization of Salmonella enterica Isolates from Turkeys in Commercial Processing Plants for Resistance to Antibiotics, Disinfectants, and a Growth Promoter. Foodborne Pathog Dis. 2011;8:593-600.
5. Whitehead RN, Overton TW, Kemp CL, Webber MA. Exposure of Salmonella enterica Serovar Typhimurium to High Level Biocide Challenge Can Select Multidrug Resistant Mutants in a Single Step. PLoS One. 2011;6:e22833.
6. Randall LP, Cooles SW, Coldham NG, Penuela EG, Mott AC, Woodward MJ, Piddock LJV, Webber MA. Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence. J Antimicrob Chemother. 2007;60(September):1273-80.
7. Piddock LJV. Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clin Microbiol Rev. 2006;19:382-402.
8. Bialek-davenet S, Marcon E, Lavigne J, Moreau R: In Vitro Selection of ramR and soxR Mutants Overexpressing Efflux Systems by Fluoroquinolones as Well as Cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55:2795-2802
9. Bailey AM, Constantinidou C, Ivens A, Garvey MI, Webber MA, Coldham N, Hobman JL, Wain J, Woodward MJ, Piddock LJV. Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother. 2009;64(September):973-85.
10. Fox EM, Leonard N, Jordan K. Physiological and transcriptional characterization of persistent and nonpersistent Listeria monocytogenes isolates. Appl Environ Microbiol. 2011;77:6559-69.
11. Bore E, Hébraud M, Chafsey I, Chambon C, Skjaeret C, Moen B, Møretrø T, Langsrud Ø, Rudi K, Langsrud S. Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses. Microbiology. 2007;153(Pt 4):935-46.
12. Condell O, Sheridan Á, Power KA, Bonilla-Santiago R, Sergeant K, Renaut J, Burgess C, Fanning S, Nally JE. Comparative proteomic analysis of Salmonella tolerance to the biocide active agent triclosan. J Proteomics. 2012;75:4505-19.
13. Sheridan Á, Lenahan M, Condell O, Bonilla-Santiago R, Sergeant K, Renaut J, Duffy G, Fanning S, Nally JE, Burgess CM. Proteomic and phenotypic analysis of triclosan tolerant verocytotoxigenic Escherichia coli O157:H19. J Proteomics. 2013;80:78-90.
14. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature. 1998;394:531-2.
15. Karatzas KAG, Webber MA, Jorgensen F, Woodward MJ, Piddock LJV, Humphrey TJ. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother. 2007;60(September):947-55.
16. Cheung H, Wong MM, Cheung S, Liang LY, Lam Y, Chiu S. Differential Actions of Chlorhexidine on the Cell Wall of Bacillus subtilis and Escherichia coli. PLoS One. 2012;7:e36659.
17. Bailey AM, Ivens A, Kingsley R, Cottell JL, Wain J, Piddock LJV. RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol. 2010;192:1607-16.
18. Mark A. Webber, Andrew M. Bailey, Jessica M. A. Blair, Eirwen Morgan, Mark P. Stevens, Jay C. D. Hinton, Al Ivens, John Wain, Piddock LJ. The Global Consequence of Disruption of the AcrAB-TolC Efflux Pump in Salmonella enterica Includes Reduced Expression of SPI-1 and Other Attributes Required To Infect the Host. J Bacteriol. 2009;191:4276-85.
19. Kastbjerg VG, Larsen MH, Gram L, Ingmer H. Influence of sublethal concentrations of common disinfectants on expression of virulence genes in Listeria monocytogenes. Appl Environ Microbiol. 2010;76:303-9.
20. Curiao T, Marchi E, Viti C, Oggioni MR, Baquero F, Martinez JL, Coque TM. Polymorphic Variation in Susceptibility and Metabolism of Triclosan-Resistant Mutants of Escherichia coli and Klebsiella pneumoniae Clinical Strains Obtained after Exposure to Biocides and Antibiotics. Antimicrob Agents Chemother. 2015;59:3413-23.
21. Webber MA, Randall LP, Cooles S, Woodward MJ, Piddock LJV. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother. 2008;62:83-91.
22. Karatzas KAG, Randall LP, Webber M, Piddock LJV, Humphrey TJ, Woodward MJ, Coldham NG. Phenotypic and Proteomic Characterization of Multiply Antibiotic-Resistant Variants of Salmonella enterica Serovar Typhimurium Selected Following Exposure to Disinfectants. Appl Environ Microbiol. 2008;74:1508-16.
23. Mangalappalli-Illathu AK, Korber DR. Adaptive resistance and differential protein expression of Salmonella enterica serovar Enteritidis biofilms exposed to benzalkonium chloride. Antimicrob Agents Chemother. 2006;50:3588-96.
24. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJV. Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J Antimicrob Chemother. 2015;70(8):2241-8.
25. Wray CSW. Experimental Salmonella typhimurium infection in calves. Res Vet Sci. 1978;25:139-43.
26. Morrissey I, Oggioni MR, Knight D, Curiao T, Coque T, Kalkanci A, Martinez JL. Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PLoS One. 2014;9:e86669.
27. Curiao T, Cantón R, Garcillán-Barcia MP, de la Cruz F, Baquero F, Coque TM. Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-beta-lactamase-producing Escherichia coli clones from humans. Antimicrob Agents Chemother. 2011;55:2451-7.
28. Bochner BR, Gadzinski P, Panomitros E. Phenotype microarrays for high-throughput phenotypic testing and assay of gene function. Genome Res. 2001;11:1246-55.
29. Foucault ML, Depardieu F, Courvalin P, Grillot-Courvalin C. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A. 2010;107:16964-9.
30. Hall BG, Acar H, Nandipati A, Barlow M. Growth rates made easy. Mol Biol Evol. 2014;31:232-8.
31. Shintre MS, Gaonkar TA, Modak SM. Efficacy of an alcohol-based healthcare hand rub containing synergistic combination of farnesol and benzethonium chloride. Int J Hyg Environ Health. 2006;209:477-87.
32. Li H, Zhang D-F, Lin X-M, Peng X-X. Outer membrane proteomics of kanamycin-resistant Escherichia coli identified MipA as a novel antibiotic resistance-related protein. FEMS Microbiol Lett. 2015;362(11) fnv074; doi: 10.1093/femsle/fnv074
33. Levengood-Freyermuth SK, Click EM, Webster RE. Role of the carboxyl-terminal domain of TolA in protein import and integrity of the outer membrane. J Bacteriol. 1993;175:222-8.
34. Czibener C, Merwaiss F, Guaimas F, Del Giudice MG, Serantes DAR, Spera JM, Ugalde JE. BigA is a novel adhesin of Brucella that mediates adhesion to epithelial cells. Cell Microbiol. 2015;18:500-13.
35. Takaya A, Kubota Y, Isogai E, Yamamoto T. Degradation of the HilC and HilD regulator proteins by ATP-dependent Lon protease leads to downregulation of Salmonella pathogenicity island 1 gene expression. Mol Microbiol. 2005;55:839-52.
36. Saini S, Rao CV. SprB is the molecular link between Salmonella pathogenicity island 1 (SPI1) and SPI4. J Bacteriol. 2010;192:2459-62.
37. McEvoy MM, Bren A, Eisenbach M, Dahlquist FW. Identification of the binding interfaces on CheY for two of its targets, the phosphatase CheZ and the flagellar switch protein fliM. J Mol Biol. 1999;289:1423-33.
38. White AP, Gibson DL, Grassl GA, Kay WW, Finlay BB, Vallance BA, Surette MG. Aggregation via the red, dry, and rough morphotype is not a virulence adaptation in Salmonella enterica serovar Typhimurium. Infect Immun. 2008;76:1048-58.
39. Lázár V, Pal Singh G, Spohn R, Nagy I, Horváth B, Hrtyan M, Busa-Fekete R, Bogos B, Méhi O, Csörgo B, Pósfai G, Fekete G, Szappanos B, Kégl B, Papp B, Pál C. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol. 2013;9:700.
40. Pal C, Papp B, Lazar V. Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol. 2015;23:401-7.
41. Rensch U, Klein G, Kehrenberg C. Analysis of Triclosan-Selected Salmonella enterica Mutants of Eight Serovars Revealed Increased Aminoglycoside Susceptibility and Reduced Growth Rates. PLoS One. 2013;8:e78310.
42. Cottell A, Denyer SP, Hanlon GW, Ochs D, Maillard J-Y. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics. J Hosp Infect. 2009;72:71-6.
43. Baquero F, Lanza VF, Cantón R, Coque TM. Public health evolutionary biology of antimicrobial resistance: priorities for intervention. Evol Appl. 2015;8:223-39.
44. Yu BJ, Kim JA, Ju HM, Choi S-K, Hwang SJ, Park S, Kim E, Pan J-G. Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli. J Microbiol. 2012;50:785-91.
45. Alvarez-Ortega C, Wiegand I, Olivares J, Hancock REW, Martínez JL. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother. 2010;54:4159-67.
46. Achouri S, Wright JA, Evans L, Macleod C, Fraser G, Cicuta P, Bryant CE. The frequency and duration of Salmonella - macrophage adhesion events determines infection efficiency. Philos Transl B. 2015;370:20140033.
47. Soscia C, Hachani A, Bernadac A, Filloux A, Bleves S. Cross talk between type III secretion and flagellar assembly systems in Pseudomonas aeruginosa. J Bacteriol. 2007;189:3124-32.
48. Zou L, Meng J, McDermott PF, Wang F, Yang Q, Cao G, Hoffmann M, Zhao S. Presence of disinfectant resistance genes in Escherichia coli isolated from retail meats in the USA. J Antimicrob Chemother. 2014;69:2644-9.
49. CMY-2 among Salmonella and other Enterobacteriaceae. J Antimicrob Chemother. 2006;57:424-9.
50. Condell O, Power KA, Händler K, Finn S, Sheridan A, Sergeant K, Renaut J, Burgess CM, Hinton JCD, Nally JE, Fanning S. Comparative analysis of Salmonella susceptibility and tolerance to the biocide chlorhexidine identifies a complex cellular defense network. Front Microbiol. 2014;5:373.
51. Giraud E, Baucheron S, Virlogeux-Payant I, Nishino K, Cloeckaert A. Effects of natural mutations in the ramRA locus on invasiveness of epidemic fluoroquinolone-resistant Salmonella enterica serovar Typhimurium isolates. J Infect Dis. 2013;207:794-802.
52. Golubeva YA, Sadik AY, Ellermeier JR, Slauch JM. Integrating global regulatory input into the Salmonella pathogenicity island 1 type III secretion system. Genetics. 2012;190:79-90.
53. Linares JF, López JA, Camafeita E, Albar JP, Rojo F, Martínez JL. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol. 2005;187:1384-91.
54. Francke C, Groot Kormelink T, Hagemeijer Y, Overmars L, Sluijter V, Moezelaar R, Siezen RJ. Comparative analyses imply that the enigmatic Sigma factor 54 is a central controller of the bacterial exterior. BMC Genomics. 2011;12:385.
55. Gantzhorn MR, Olsen JE, Thomsen LE. Importance of sigma factor mutations in increased triclosan resistance in Salmonella Typhimurium. BMC Microbiol. 2015;15:105.
56. Casey A, Fox EM, Schmitz-Esser S, Coffey A, McAuliffe O, Jordan K. Transcriptome analysis of Listeria monocytogenes exposed to biocide stress reveals a multi-system response involving cell wall synthesis, sugar uptake, and motility. Front Microbiol. 2014;5:1-10.
57. Russell AD. Mechanisms of antimicrobial action of antiseptics and disinfectants: an increasingly important area of investigation. J Antimicrob Chemother. 2002;49:597-9.
58. Maillard J-Y. Bacterial target sites for biocide action. J Appl Microbiol. 2002;92(Suppl):16S-27S.